Abstract Corruption is diverse in its forms and embedded in health systems worldwide. Health-sector corruption directly impedes progress towards universal health coverage by inhibiting people's access to quality health services and to safe and effective medicines, and undermining systems for financial risk protection. Corruption is also a cross-cutting theme in the United Nations' sustainable development goals (SDGs) which aim to improve population health, promote justice and strong institutions and advance sustainable human development. To address health-sector corruption, we need to identify how it happens, collect evidence on its impact and develop frameworks to assess the potential risks and put in place protective measures. We propose that the SDGs can be leveraged to develop a new approach to anti-corruption governance in the health sector. The aim will be to address coordination across the jurisdictions of different countries and foster partnerships among stakeholders to adopt coherent policies and anti-corruption best practices at all levels. Combating corruption requires a focused and invigorated political will, better advocacy and stronger institutions. There is no single solution to the problem. Nevertheless, a commitment to controlling corruption via the SDGs will better ensure the integrity of global health and human development now and beyond 2030.
Introduction
Corruption is the abuse of entrusted power for private gain. 1 The concept of corruption in relation to global health has been defined as: "misappropriation of authority, resources, trust or power for private or institutional gain that has adverse effects on regional, local or international health systems and/or that negatively impacts individual patient and/or population health outcomes." 2 A study in 2013 by Transparency International, a global civil society organization working against corruption, found that in 42 out of 109 countries surveyed, more than 50% of citizens believed that the health sector in their country was corrupt or very corrupt. 3 The adverse effects of corruption are not only financial: there are societal and human costs too, especially in lowincome settings. A study in 20 African countries found that a higher perceived level of national corruption was associated with poorer health, with a more detrimental impact among people of lower socioeconomic status. 8 A study demonstrated significant association between child mortality and national perceived levels of corruption, with estimates that up to 140 000 annual child deaths could be indirectly attributed to corruption. 9 The immediate and delayed effects of corruption on health outcomes, including higher morbidity and mortality, are due to the barriers it creates to access to health-care services, particularly for the most vulnerable groups of the population. Corruption has a negative impact on healthsystem quality, while distorting the allocation of countries' health investments. 9 Corruption also slows progress towards achieving universal health coverage (UHC), a unifying strategy to achieve the United Nations' (UN) sustainable development goal (SDG) 3, as set out in Transforming our world: the 2030 agenda for sustainable development. 10 SDG 3 focuses on ensuring healthy lives and promoting well-being for all. Specifically, corruption negatively impacts SDG 3 by impeding people's access to quality health services and to safe and effective medicines, while also undermining systems for financial risk protection. Addressing health corruption complements the right to health, a principle enshrined in international law through the Universal Declaration of Human Rights and WHO Constitution, 11, 12 and which underpins UHC and the SDG health-related targets and indicators.
This article aims to identify and characterize the main types of health-sector corruption and explore frameworks for assessing risks of corruption and identifying protective factors. We also outline international efforts to combat health-sector corruption. Finally, we propose a new health corruption governance framework embedded within the 2030 agenda. We hope that such a framework could help catalyse international action to combat corruption in the health-care setting.
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Challenges
There are many reasons why the health sector is vulnerable to corruption. 13, 14 Important factors include the complexities of national health-care systems, which often combine both public and private health-care providers, and the large numbers and categories of people involved (patients, providers, insurers, administrators, distributors, dispensers and policymakers). Another factor is the globalized nature of the supply chain for health-care products, which increases the number of points in the system that are susceptible to corruption. The large amounts of public and private spending involved (including the high costs of administration and increased international development assistance for health programmes) also create opportunities for corruption. Finally, there are information asymmetries between actors when one party has more or better information than another, which can impact negatively health-care decisionmaking. These vulnerabilities that can lead to corruption can weaken health systems, waste resources and reduce the resilience of countries to health emergencies, leading to compromised coverage and access to essential healthcare services.
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Types of corruption
Global health-sector corruption is multifaceted and involves the jurisdictions of different countries. The United Nations Convention Against Corruption (UNCAC) is an international, legally binding treaty aimed at preventing, criminalizing and establishing international cooperation and information-sharing to fight corruption. Signatory countries to the UNCAC agree to criminalize bribery, embezzlement, misappropriation, diversion of property by public officials, trading in influence, abuse of functions and illicit enrichment as specific categories of corruption. 2, 17 Notably, bribery and embezzlement in the private sector is also criminalized, as well as money-laundering. Another form of corruption that particularly affects health-care reimbursement systems is fraud, defined as intentional deception or misrepresentation made with the knowledge that the deception could result in unauthorized benefits. 18 The scale of corruption in the health sector can range from bureaucratic corruption (involving interactions between citizens and frontline workers or government agents) to corruption at the highest levels of policy or legislative decision-making. 19 A WHO report 6 identified practices ranging from theft and diversion of medicines and medical devices across the international healthsupply chain, to widespread medical billing and insurance fraud for services never rendered. Specific to the health sector, forms of corruption include: informal payments by patients to providers; absenteeism (workers who are legitimately on a payroll but are chronically absent without approval); ghost workers (nonexistent individuals receiving salaries through the payroll system); reimbursement fraud (requesting insurance payments for services not rendered); dual practice (clinicians with salaries in the public sector who also maintain a private practice to divert patients or resources for their own financial gain); and improper marketing (promoting a drug for a clinical indication that is not approved for use; misleading marketing claims). 2, [14] [15] [16] [19] [20] [21] These problems, however, may originate from other causes, such as unintentional errors or omissions, or may constitute only an ethics violation, not an actual crime, based on a country's applicable laws and regulations. Other forms of health corruption are multi-jurisdictional and may involve transnational criminal networks, such as the international trade in falsified and substandard medicines, or organized criminal networks that are directly involved in health fraud schemes in multiple countries. 22, 23 Importantly, types of health corruption can occur across multiple dimensions of the health sector, with Transparency International identifying eight key areas of susceptibility: (i) healthsystems governance; (ii) health-systems regulation; (iii) research and development; (iv) marketing; (v) procurement; (vi) product distribution and storage; (vii) financial and workforce management; and (viii) delivery of health-care services (Table 1) .
Existing data on corruption
Recent reviews have synthesized evidence of corruption in the health sector in different countries and contexts. 14, 20, 25 Corruption is often measured using surveys of peoples' perceptions or experiences (e.g. Transparency International's global corruption barometer survey) 3 or social audits (e.g. household surveys that include questions about perceptions and experiences with corruption). There have also been special studies focused on problems such as ghost workers or unjustified absenteeism. 4, 14, 16, 26, 27 Other official sources are investigative reports by oversight agencies, such as a national agency responsible for auditing government revenue and spending or an ombudsman's office comprised of officials charged with investigating complaints of corruption. Reports generated by the media and investigative journalism also can serve as important alerts and uncover corruption for further investigation. Other data sources, including health commodity procurement prices and enforcement data (e.g. number and amount of settlements for corruptionrelated prosecutions), act as useful proxy indicators.
Additionally, qualitative studies documenting people's lived experience with corruption in the health sector provide specific details that go beyond perception surveys. For example, a systematic review of 38 research studies found a huge range in the proportions of patients who reported making informal payments in the health-care system (from 2% to 80%). 28 Similarly, surveys in Africa found that the percentage of people paying bribes to obtain health-care services ranged from 1% of 1200 people surveyed in Botswana to 69% of 1199 people in Liberia. 29 In a study of the 28 Member States of the European Union, 8704 (31%) of 28 080 respondents thought that corruption was widespread in their health-care system. Yet only 872 (4%) of 21 789 respondents reported having to give an extra payment, valuable gift or make a donation to the hospital to access care. The highest proportions of informal payments were in Greece (13%), Hungary (17%) and Romania (19%; numbers not reported). 30 Overall, variability in data quality, sources and methods of analysis and a general lack of systematic and standardized data collection make it hard to generalize the actual prevalence and overall trends in different categories of health corruption across different countries. Theft, embezzlement and misallocation of health-care funds Unjustified absenteeism (workers who are legitimately on a payroll, but are chronically absent without approval) Dual practice (when clinicians who have salaries in the public sector also maintain a private practice to divert patients or resources for their own financial gain) Improper billing or payments, upcoding (when a provider bills for a service that is more expensive than the one performed), and false claims Self-referral (when a health-care provider refers a patient to an entity they have a financial relationship with) Ghost workers (non-existent individuals receiving salaries through the payroll system) Inappropriate selection for jobs, promotions and training (continues. . .) 20 on intentional integrity violations (a more inclusive term than corruption). Transparency International's framework considers the relationships among five major categories of people: (i) government regulators (ministries, parliaments, commissions); (ii) payers (social security, government, private insurers); (iii) providers (hospitals, doctors, pharmacists); consumers (patients); (iv) drug and equipment suppliers (pharmaceutical and medical device companies); (v) and other suppliers (hospital construction companies). This framework illustrated how fragmentation and delegation of responsibilities through a decentralized health system can increase the system's vulnerability to corruption.
Frameworks for assessing corruption
In 2017 a European Commission study was made to establish the types of health corruption that may put health systems at heightened risk. 25 Three issues were identified: (i) privileged access to medical services (including informal payments and misuse of privileged information); (ii) improper marketing (including for market authorization and reimbursement); and (iii) dual practice.
A 2008 review of health-sector corruption presented a model of factors that occur at the individual level, driven by pressures, opportunities and rationalizations to abuse. These individual-level drivers then translate to risks for corruption that manifest at the larger healthsystems level and are driven by other macro risk factors such as weak citizen voices (limited participation by citizens in planning and monitoring government services) and monopoly (limiting citizen choices and forcing interaction with corrupt agents). 16 This framework conceptualized corruption as the result of individual actions and systems-level problem, requiring strategies that recognize and address risk factors at both these levels. 16, 31 Anti-corruption strategies and tactics to control corruption in the health sector often focus on protective factors, including good governance approaches centred on the rule of law, transparency, accountability and participation. Transparency, in particular, is key to mitigating the risks of corruption by ensuring information is publicly available, as in e-government (i.e. use of electronic devices to provide services to citizens), open contracting and e-procurement approaches. [32] [33] [34] Accountability to the public by public officials is also essential to foster trust in public institutions, the decision-making processes and governance, with the overall aim of assessing the achievement of goals laid out by government against the standards and commitments made. 35 Importantly, these good governance concepts have clear linkages (e.g. accountability is difficult to ascertain without transparency) and, independently, accountability or transparency alone cannot sufficiently curb corrupt practices.
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International efforts
Current international efforts to fight health corruption are built on strategies that emerged as early as the 1970s. For example, the United States Foreign Corrupt Practices Acts was enacted due to investigations by the United States Securities and Exchange Commission and United States Senate sub-Committee on Multinational Corporations. These investigations uncovered over US$ 300 million in illegal payments by over 400 American companies, including pharmaceutical and health-care corporations. 38 In 1999, the OECD's Anti-Bribery Convention was adopted internationally to criminalize bribery of foreign public officials in international business transactions. The Convention followed ministerial decisions to make anti-corruption a policy priority for the World Bank and the International Monetary Fund. As a first anti-corruption step by the UN, the non-binding UN Global Compact at the end of the 1990s established principle 10 to encourage businesses to fight corruption. This was followed by other anti-corruption activities from the International Chamber of Commerce, which rewrote its Rules on combating corruption in 2011, 39 and the World Economic Forum, whose Partnering Against Corruption initiative was launched in 2004. 40 It was not until 2005, however, that the UN's global anti-corruption efforts came to the fore, with the adoption of the UNCAC by the United Nations Office of Drugs and Crime (UNODC). The UNCAC created the first global treaty aimed at preventing, criminalizing, controlling and strengthening international cooperation against corruption in all its forms. 2 Near universal adoption of the UNCAC by UN Member States also helped support anti-corruption programmes in many multilateral development institutions, such as the World Bank, regional development banks (as well as leading bilateral aid agencies) and the United Nations Development Programme (UNDP). These institutions identified corruption as one of the biggest obstacles to social and economic development and adopted good governance and anti-corruption programmes in response.
Health corruption category
Description
Potential health system actors
Specific examples
Delivery of healthcare services 
Specific to health, the WHO launched the Good Governance for Medicines programme in 2004, which sought to prevent corruption by promoting transparency in the pharmaceutical sector. 41 More recent developments from the WHO include an update to its Good Governance for Medicines programme tool and a workstream led by the healthsystems governance and financing team and the gender, equity and rights team. This project aims to advance work on strengthening transparency and accountability in health systems, including specifically linking anti-corruption efforts to UHC.
Global health partnerships, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, have also attempted to address corruption more proactively. This followed from damaging reports of misallocation, fraud, collusion in bidding and drug theft in their country programmes. 13, 42, 43 Global Fund anti-corruption initiatives include the I Speak Out Now campaign and its Two to One penalty that withholds double the amount of future grant funding when lost funds are not recovered. Yet, despite a variety of anti-corruption programmes and initiatives in place from different stakeholders, a recent 2016 Cochrane review found that no studies met their criteria for establishing empirical evidence of the effect of anti-corruption interventions in the health sector. 44 The lack of evidence of effectiveness may be due in part to inadequate enforcement, particularly in the context of multi-jurisdictional corruption that requires international cooperation and coordination.
Policy proposal
The SDGs offer a valuable opportunity and governance mechanism to tackle health corruption. Whereas the healthrelated millennium development goals focused primarily on infectious diseases and maternal and child health, the SDGs now explicitly declare promoting healthy lives and combating corruption as central pillars of the international policy and global governance. The SDGs can therefore be an organizing framework for international action against multi-jurisdictional health corruption. Nevertheless, the global health community needs to develop consensus around definitions and categories of corruption, standardize and enable collection of more robust data, and deploy tools to assess risk and protective factors at the individual and systems level.
To better understand the interplay between these interdependent SDG drivers of health, social justice and economic growth, we mapped the SDG goals, targets and indicators associated with health corruption (Table 2  and Table 3 ). We included SDG goal 3 targets 3.8 (achieving UHC including access to quality essential health-care services and medicines), 3c (increasing health-care financing and retention of health workforce) and 3d (strengthening capacity of countries to respond to global health risks), along with four specific SDG indicators on how progress towards targets are measured. SDG goal 16 includes targets 16.5 (substantially reduce bribery and corruption) and 16.6 (develop effective, accountable and transparent institutions at all levels) and three indicators. We also provide practical examples of categories of health corruption that impact each SDG target. Our most important finding is that none of the SDG goal 3 or goal 16 associated targets or indicators addresses health corruption directly. approval. e Collusion in contracting is when there is a secret agreement between suppliers to conspire and commit actions to deceive a competitive bidding/tender process. f Ghost workers are non-existent individuals receiving salaries through the payroll system.
In Table 4 we formulate examples of cross-cutting SDG sub-indicators that could be deployed to prevent, control and fight corruption to improve public health and we map them to existing SDG targets and indicators. These sub-indicators focus on addressing and measuring: (i) bribery and its impact on health-care access; (ii) health-care funds lost to fraud, abuse, misuse and embezzlement; (iii) corruption and its impact on quality and access to medicines (including falsified and substandard medicines); (iv) the effect of investment in health strengthening and good governance; and (v) the negative interaction between corruption and global health security. These sub-indicators also provide examples of how data could be collected, analysed and measured, using different methods and tools. Such tools include data from surveys, community monitoring, prosecutions and enforcements, audits, public health surveillance and monitoring and evaluations.
Finally, SDG goal 17, which focuses on multistakeholder partnerships, is crucial to putting into practice a shared agenda in global health governance against corruption. Specifically, targets 17.14 (enhancing policy coherence) and 17.16 (enhancing global partnership around SDGs by complementing with multistakeholder partnerships) can help focus and advocate for needed attention on corruption risk in the health sector. This process begins with UN specialized agencies, international treaties (e.g. such as monitoring implementation of the UNCAC in the context of health) and anti-corruption programmes at different levels, aligning their policies more coherently though standardized definitions and use of best practices as part of target 17.14.
Coherence across global policy can be achieved by promoting best practices in anti-corruption, good governance, audit, transparency and accountability, and integrating them in policy instruments. These best practices include national health policies, strategies and plans; capacity-building activities, such as health-system strengthening efforts; and monitoring and evaluation, such as health sector assessments. Furthermore, given the lack of empirical data supporting anti-corruption interventions, there is an immediate need to conduct robust evaluations of the effectiveness and impact of different domestic and international anti-corruption laws (such as the Foreign Corrupt Practices Act of the United States, the Bribery Act 2010 of the United Kingdom of Great Britain and Northern Ireland and the UNCAC) that are used to control health-related corruption in all its forms. 2, 13 Finally, relevant UN institutions could mobilize this SDG-focused agenda by building global multistakeholder partnerships aimed at achieving shared goals of SDGs 3 and 16 as part of target 17.16. Initial participating organizations could include UNDP, WHO, UNODC (which promotes the UNCAC and houses UNCAC's Conference of the State Parties) and the World Bank. Additionally, non-state civil society organizations such as Transparency International and the U4 Anti-Corruption Resource Centre 15 should also have some form of participation in SDG partnerships to provide insights on community engagement, conduct anti-corruption research and act as a resource for anti-corruption training.
Conclusion
Corruption in the health sector is a major challenge to advancing population health, social justice, shared prosperity and sustainable development, all of which are core pillars of the SDGs. Efforts to prevent corruption need to begin with international consensus, recognizing the unique and destructive consequences of health-sector corruption. We offer a blueprint for how global stakeholders can use the SDG framework to advocate and pri- oritize combating corruption's impact on health. We call for the UN's Interagency Expert Working Group on SDG Indicators to partner with the WHO to hold consultations on the formation of a multistakeholder health-corruption partnership under the SDGs. 13 We argue that combating corruption should be a core value of the SDGs, due to its links to human rights, equity, economic development and UHC. Combating the disease of corruption is critical to ensur- 
Résumé
Les objectifs de développement durable en tant que cadre pour lutter contre la corruption dans le secteur de la santé La corruption revêt diverses formes et mine les systèmes de santé du monde entier. La corruption dans le secteur de santé entrave directement les progrès en faveur de la couverture sanitaire universelle en empêchant l'accès de la population à des services de santé de qualité et à des médicaments sûrs et efficaces, et en ébranlant les systèmes de protection contre le risque financier. La corruption est également une thématique transversale des objectifs de développement durable (ODD) des Nations Unies, qui visent à améliorer la santé de la population, à promouvoir la justice et des institutions efficaces, et à favoriser le développement humain durable. Pour combattre la corruption dans le secteur de la santé, il est nécessaire de déterminer comment elle se produit, de collecter des données sur son impact et d'élaborer des cadres pour évaluer les risques potentiels et mettre en place des mesures de protection. Nous suggérons de tirer parti des ODD pour développer un nouveau système de gouvernance anticorruption dans le secteur de la santé. L'objectif sera d'assurer la coordination entre les systèmes juridiques des différents pays et d'encourager les partenariats entre les parties prenantes en vue de l'adoption de politiques cohérentes et de pratiques anticorruption exemplaires à tous les niveaux. La lutte contre la corruption exige une volonté politique ciblée et dynamisée, une prise de position renforcée et des institutions plus efficaces. Il n'existe pas de solution unique à ce problème. Néanmoins, un engagement en faveur de la lutte contre la corruption par le biais des ODD permettra de mieux assurer l'intégrité de la santé mondiale et du développement humain jusqu'à 2030 et au-delà.
Резюме
Цели в области устойчивого развития в качестве основы для борьбы с коррупцией в секторе здравоохранения Коррупция имеет различные формы и внедрена в системы здравоохранения во всем мире. Коррупция в секторе здравоохранения напрямую препятствует прогрессу в обеспечении всеобщего охвата медико-санитарным обслуживанием, препятствуя доступу людей к качественным медицинским услугам и безопасным и эффективным лекарственным средствам, а также подрывает системы защиты от финансовых рисков. Коррупция также является сквозной темой в целях в области устойчивого развития (ЦУР) Организации Объединенных Наций, которые направлены на улучшение здоровья населения, содействие правосудию, укрепление институтов и обеспечение устойчивого развития человеческого потенциала. Для борьбы с коррупцией в секторе здравоохранения нам необходимо определить, как это происходит, собрать фактические данные о ее влиянии и разработать основы для оценки потенциальных рисков и принятия защитных мер. Мы предлагаем использовать ЦУР для разработки нового подхода к борьбе с коррупцией в секторе здравоохранения. Цель будет заключаться в обеспечении координации между юрисдикциями разных стран и укреплении партнерских отношений между заинтересованными сторонами для принятия согласованной политики и лучшей практики борьбы с коррупцией на всех уровнях. Борьба с коррупцией требует целенаправленной и активной политической воли, более эффективной пропаганды и укрепления институтов. Единого решения проблемы не существует. Тем не менее приверженность борьбе с коррупцией с помощью ЦУР будет лучше обеспечивать целостность глобального здравоохранения и развития человеческого потенциала в настоящее время и после 2030 года.
Resumen
Los objetivos de desarrollo sostenible como marco para combatir la corrupción en el sector de la salud La corrupción es diversa en sus formas y está incrustada en los sistemas de salud de todo el mundo. La corrupción en el sector de la salud impide directamente el progreso hacia la cobertura universal de la salud al cohibir el acceso de las personas a servicios de salud de calidad y a medicamentos seguros y eficaces, y debilitar los sistemas de protección contra los riesgos financieros. La corrupción es también un tema transversal en los objetivos de desarrollo sostenible (ODS) de las Naciones Unidas, cuyo objetivo es mejorar la salud de la población, promover la justicia y el fortalecimiento de las instituciones y promover el desarrollo humano sostenible. Para hacer frente a la corrupción en el sector de la salud, es necesario identificar cómo se produce, recopilar pruebas de su impacto y desarrollar marcos para evaluar los riesgos potenciales y establecer medidas de protección. Se propone aprovechar los ODS para desarrollar un nuevo enfoque de la gobernanza Policy & practice Combating health corruption Tim K Mackey et al.
anticorrupción en el sector de la salud. El objetivo será coordinar las distintas jurisdicciones de los distintos países y fomentar las asociaciones entre las partes interesadas para adoptar políticas coherentes y prácticas óptimas de lucha contra la corrupción a todos los niveles. La lucha contra la corrupción requiere una voluntad política centrada y fortalecida, una mejor promoción y el fortalecimiento de las instituciones. No existe una única solución al problema. Sin embargo, el compromiso de controlar la corrupción a través de los ODS garantizará mejor la integridad de la salud mundial y el desarrollo humano actual y después de 2030.
